The Design Is Done. The License Is Not.

The Design Is Done. The License Is Not.

Hazer Group has spent more than a decade and roughly $140 million building a proprietary process that turns natural gas into clean hydrogen and solid carbon graphite. It has completed the engineering design package for commercial-scale plants, filed about 100 patents, lined up engineering partner KBR, and assembled a pipeline of 40 to 50 commercial pursuits. The company tells you it has moved from laboratory development to commercial execution.

The market disagrees. Hazer shares trade around $0.35 on the ASX, down from a 52-week high of $0.635, with a market capitalization near $92 million. The price action says investors still see a research project, not a revenue business.

They're not wrong. Hazer has not yet signed a single binding commercial license.

But the question isn't whether the technology is finished — it's whether the licensing model can close enough deals to justify the capital base before the cash runs out. That's what separates this from a pure speculation: the runway is finite, the engineering is done, and the next 12 months are about deal signatures, not more lab work.

The business, stripped down

The Hazer Process is a methane pyrolysis technology. It takes natural gas and an iron-ore catalyst, separates the molecules, and produces hydrogen and solid carbon graphite — no CO₂ from the reaction itself. The graphite is not waste; it's a high-purity co-product (99.99%) that can be sold into batteries, steelmaking, and industrial applications. Hazer says it produces roughly 3.5 tonnes of graphite for every tonne of hydrogen.

That dual-output structure is the economic argument. Management targets hydrogen production costs of $1 to $2 per kilogram at scale in Australia — on par with conventional steam methane reforming and well below green hydrogen at roughly $15/kg. The graphite co-product provides additional revenue to push the economics further.

After years of pilot work and scale-up, the completed milestone this year is the Process Design Package for a 30,000-tonne-per-year hydrogen plant, done jointly with engineering firm KBR. The PDP is the document that large industrial customers need before they'll commit capital. Hazer now has it. The engineering question is, for practical purposes, answered.

What the numbers actually show

Hazer's last full-year revenue (FY25, ended June 2025) was $8.5 million, up 124% from the prior year's $3.8 million. But $4.3 million of that FY25 revenue came from government grant income — not customer contracts. In the first half of FY26 (ended December 2025), revenue fell to $1.5 million, with a net loss of $5 million. The business is not generating operating cash flow. It never has.

The cash position tells a clearer story. As of June 30, 2026, Hazer held $11 million in cash, plus $2.3 million in pending government grants, for a total funding position of $13 million. Quarterly operating cash burn runs under $2 million. That implies roughly six to seven quarters of runway at current burn rates, assuming no dilutive capital raise, no binding revenue comes through, and grant income flows as expected.

This is not a comfort margin. Six quarters of runway means two decisions must happen inside that window: the first binding license, and then a second deal that starts generating real engineering-service revenue. Management says three to four projects moving through the engineering-service phase could achieve cash neutrality. That's the financial bridge — not a vague "eventual profitability" claim, but a specific number of deals required to stop the bleed.

The pipeline versus the blank page

Here's what's advancing:

The Whyalla steelworks opportunity in South Australia is the closest to a meaningful headline. Hazer has a binding memorandum of understanding with M Resources, which is bidding to acquire the steelworks. A win would embed Hazer's technology at the heart of a major Australian industrial decarbonization project. A final decision was expected in the latter half of calendar 2026. This is not a license yet — it's a bid contingency.

In Canada, Hazer is working with KBR and FortisBC on a 2,500-tonne commercial facility, moving through engineering and economic assessment. In the UK, a paid concept study with EnergyPathways is underway at the Marram Energy Storage Hub — the first project under the KBR alliance. In South Korea, work with POSCO continues around integrating Hazer technology into POSCO's HyREX hydrogen-based iron reduction process, targeting operational facilities by 2030.

Then there's the graphite angle. In March 2026, Hazer signed a non-binding letter of intent with Green Steel of WA for up to 85,000 tonnes of graphite over 10 years — about 8,500 tonnes annually starting in 2030. Pricing is linked to anthracite, currently around $400 per tonne, minus 5%. At those numbers, the potential value is roughly $340,000 per year, or $3.4 million over the decade. That's meaningful for graphite monetization, but it's an LOI, not a contract, and deliveries don't start until 2030.

None of these are binding revenue commitments. None of them put cash in the bank today.

What a single license is worth — and why it matters

Management estimates each license for a 30,000 to 50,000-tonne plant could generate $50 million to $100 million in revenue over time, through upfront fees, engineering services, and royalties. That's a large number, and it needs the usual skepticism. Revenue is not cash flow, not profit, and not received upfront. But it does establish the addressable value per deal, which is critical for understanding whether three to four licenses can actually close the cash-neutral gap.

The licensing model is also the reason this company doesn't face the dilution trap that kills most pre-revenue technology businesses. Hazer isn't building the plants — its partners are. The company sells the IP, the design, and the engineering expertise. That keeps the balance sheet clean and avoids the capital-raise treadmill. It also means Hazer's revenue is back-ended: the biggest payments come during FEED work, construction, and then through ongoing royalties.

The bear case, stated plainly

The strongest argument against Hazer is that the technology has been "almost ready" for years, and the stock has traded around the same level through multiple rounds of pilot announcements, partnership signings, and management presentations. $140 million invested over a decade with zero binding revenue suggests execution difficulty that hasn't been priced out — it's been priced in at the lowest reasonable valuation.

The hydrogen economy is crowded. Steam methane reforming with carbon capture (blue hydrogen) is cheaper at scale and already deployed. Green hydrogen from electrolysis has massive government subsidy stacks behind it. Methane pyrolysis occupies a narrow cost-corridor between them, dependent on graphite co-product revenue and favorable natural gas pricing. If graphite demand disappoints, if natural gas prices spike, or if the carbon credit economics shift, Hazer's cost advantage shrinks.

There's also the partner-dependency risk. Hazer can't build a plant on its own. It needs steelmakers, energy companies, or project developers to commit tens or hundreds of millions in capex to the Hazer Process. Those decisions are made by committees, not CEOs, and they move slowly. A pipeline of 40 to 50 pursuits sounds impressive until you realize most of them are conversations, not term sheets.

The condition that must hold

If the licensing thesis is real, it should be possible to say what would prove it wrong. It's not the stock price. The break condition is the cash runway.

Hazer has roughly six to seven quarters at current burn rates. If the first binding commercial license is not signed before that runway narrows to a danger zone, the market will move from "late but possible" to "never arriving," and the equity value will collapse accordingly. The next 18 months are the test period. The Whyalla decision, the Canada and UK project progress, and whether any of the 40-to-50 pursuits converts to a signed deal — those are the observable variables.

Conversely, if one binding license does close in the next 12 months, the dynamic changes. The technology stops being a question mark and becomes a proven commercial platform. The market cap of $92 million against a $50-to-$100-million-per-license revenue potential creates an asymmetry: the market is pricing a pre-revenue research company, not a proven IP platform with a backlog. That rerating would come from the deal signature itself, not from complex valuation models — which tend to manufacture precision that doesn't exist anyway.

Where this sits

Hazer is not a business you buy for its cash flow today. It's a capital-light technology platform that has completed the engineering work and now needs to close the commercial deals. The risk is real and material: the company could spend its remaining cash without ever signing a binding license. The upside is also real and material: one closed deal changes the entire narrative, and the licensing model means the company doesn't need to raise hundreds of millions to prove itself.

The market is still pricing the old risk profile — a decade-long research project with no revenue — while the operating setup has moved past lab work and into commercial execution. The question is whether execution matches the engineering progress. The numbers give it a narrow window. Either a license closes within the next 18 months, or the runway runs out and the equity goes to zero. There's no comfortable middle ground.